NASDAQ: GLPG       Galapagos NV
Last Price Today's Change   Day's Range   Trading Volume
198.45   -1.23 (0.62%)  198.45 - 203.46  37,320


Avg Volume (4 weeks):135,036
4 Weeks Range:194.88 - 233.14
4 Weeks Price Volatility (%):
52 Weeks Range:112.00 - 274.03
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Galapagos is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company’s product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3879  1824  371  2881 

Top 10 Active Counters
 CIDM 3.82+2.51 
 VISL 0.977+0.552 
 AAL 15.08+3.23 
 GNUS 4.74-3.19 
 XSPA 1.745+0.665 
 NIO 6.11+0.51 
 AVP 5.60-0.05 
 DAL 32.31+3.84 
 UAL 38.90+5.25 
 SAVE 21.53+4.22 
Partners & Brokers